Migraine Headache Therapy
Active substance: ATROPA BELLADONNA, BRYONIA ALBA ROOT, BLACK COHOSH, ARABICA COFFEE BEAN, NITROGLYCERIN, IRIS VERSICOLOR ROOT, SODIUM CHLORIDE
TABLET, ORALLY DISINTEGRATING · ATROPA BELLADONNA 6 [hp_X]/1, BRYONIA ALBA ROOT 6 [hp_X]/1, BLACK COHOSH 6 [hp_X]/1, ARABICA COFFEE BEAN 3 [hp_X]/1, NITROGLYCERIN 12 [hp_X]/1, IRIS VERSICOLOR ROOT 6 [hp_X]/1, SODIUM CHLORIDE 6 [hp_X]/1
United StatesActive
Marketing holder: TRP Company
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ATROPA BELLADONNA · 6 [hp_X]/1
- BRYONIA ALBA ROOT · 6 [hp_X]/1
- BLACK COHOSH · 6 [hp_X]/1
- ARABICA COFFEE BEAN · 3 [hp_X]/1
- NITROGLYCERIN · 12 [hp_X]/1
- IRIS VERSICOLOR ROOT · 6 [hp_X]/1
- SODIUM CHLORIDE · 6 [hp_X]/1
Registration
- Registration number
- 17312-041
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 17312-041 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 17312-041 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 17312-041 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 17312-041 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 17312-041 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 17312-041 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 17312-041 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 17312-041 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 17312-041 · Verified 2026-10-09 · open in source